Alzamend Neuro (ALZN) Institutional Ownership $1.24 -0.03 (-2.36%) As of 03:59 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Alzamend Neuro (NASDAQ:ALZN)CurrentInstitutional OwnershipPercentage49.61%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$264.82KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$19.23M Get ALZN Insider Trade Alerts Want to know when executives and insiders are buying or selling Alzamend Neuro stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ALZN Institutional Buying and Selling by Quarter Ad Diversified Trading InstituteCombine the QQQ, IWM and SPY in one tradeIf you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses…You can find out about this “2-Click Trade” here. Alzamend Neuro Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024Virtu Financial LLC26,482$26K0.0%N/A0.385% 2/2/2024Truist Financial Corp154,327$137K0.0%-93.3%2.168% 5/11/2022RFG Advisory LLC250,000$308K0.0%N/A0.277% 5/9/2022Qube Research & Technologies Ltd78,465$97K0.0%N/A0.087% 4/22/2022Truist Financial Corp2,314,907$2.85M0.0%N/A2.569% 1/31/2022Commonwealth Equity Services LLC116,666$221K0.0%N/A0.131% 11/16/2021Schonfeld Strategic Advisors LLC31,600$97K0.0%N/A0.036% 11/16/2021Two Sigma Investments LP172,913$533K0.0%N/A0.199% 11/16/2021Warberg Asset Management LLC14,000$43K0.0%N/A0.016% 11/15/2021Sassicaia Capital Advisers LLC93,762$289K0.8%N/A0.108% 9/17/2021Virtu Financial LLC15,402$135K0.0%N/A0.018% 8/16/2021Cubist Systematic Strategies LLC23,672$207K0.0%N/A0.028% 8/13/2021Geode Capital Management LLC44,600$389K0.0%N/A0.052% 8/11/2021Susquehanna International Group LLP57,030$498K0.0%N/A0.067% (Data available from 1/1/2016 forward) ALZN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ALZN shares? During the previous two years, the following institutional investors and hedge funds held shares of Alzamend Neuro shares: Truist Financial Corp ($137K), Virtu Financial LLC ($26K).Learn more on ALZN's institutional investors. What percentage of Alzamend Neuro stock is owned by institutional investors? 49.61% of Alzamend Neuro stock is owned by institutional investors. Learn more on ALZN's institutional investor holdings. Which institutional investors have been buying Alzamend Neuro stock? The following institutional investors have purchased Alzamend Neuro stock in the last 24 months: Virtu Financial LLC ($26.48K). How much institutional buying is happening at Alzamend Neuro? Institutional investors have bought a total of 26,482 shares in the last 24 months. This purchase volume represents approximately $264.82K in transactions. Which Alzamend Neuro major shareholders have been selling company stock? The following institutional investors have sold Alzamend Neuro stock in the last 24 months: Truist Financial Corp ($2.16M). How much institutional selling is happening at Alzamend Neuro? Institutional investors have sold a total of 2,160,580 shares in the last 24 months. This volume of shares sold represents approximately $19.23M in transactions. Related Companies CEL-SCI Institutional Ownership LAVA Therapeutics Institutional Ownership Equillium Institutional Ownership DURECT Institutional Ownership Lipocine Institutional Ownership Natural Alternatives International Institutional Ownership Enlivex Therapeutics Institutional Ownership Pluri Institutional Ownership NextCure Institutional Ownership IN8bio Institutional Ownership This page (NASDAQ:ALZN) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALZN Stock Alerts